LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Locked nucleic acid (LNA) is a nucleic acid analogue containing one or more LNA nucleotide monomers with a bicyclic furanose unit locked in an RNA mimicking sugar conformation. LNA oligonucleotides display unprecedented hybridization affinity toward complementary single-stranded RNA and complementary single- or double-stranded DNA. Structural studies have shown that LNA oligonucleotides induce A-type (RNA-like) duplex conformations. The wide applicability of LNA oligonucleotides for gene silencing and their use for research and diagnostic purposes are documented in a number of recent reports, some of which are described herein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antisense oligonucleotides are an attractive therapeutic strategy because they can inhibit mRNA expression specifically [7, 8].”
From Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors (2014) · cites this paper as [8]
Citations
Cites
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Self-citationAn autonomous molecular computer for logical control of gene expression
Benenson, Y., Gil, B., Ben-Dor, U., Adar, R., & Shapiro, E. (2004) · Nature · doi:10.1038/nature02551 · Cited by 821
LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition
Singh, S. K., Koshkin, A. A., Wengel, J., & Nielsen, P. (1998) · Chemical Communications · doi:10.1039/a708608c · Cited by 768
Self-citationObika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
LNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
Self-citationObika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Design of antisense oligonucleotides stabilized by locked nucleic acids
Kurreck, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1911 · Cited by 577
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Self-citation
Research works printed but not linked: 39
- Jepsen J. S., 2004, Curr. Opin. Drug Discovery Dev. 7, 188−194.
- Singh S. K., 1998, Chem. Commun. 4, 455−456.
- Koshkin A. A., 1998, Cytosine, Guanine, 5-Methylcytosine, Thymine and Uracil Bicyclonucleoside Monomers, Oligomerisation, and Unprecedented Nucleic Acid Recognition, Tetrahedron 54, 3607−3630.
- Wengel J., 1999, Acc. Chem. Res. 32, 301−310.
- McTigue P. M., 2004, Biochemistry 43, 5388−5405.
- Nielsen K. E., 2004, Bioconjugate Chem. 15, 449−457.
- Nielsen K. M. E., 2002, Chem.Eur. J., 8
- Nielsen J. T., 2003, Nucleic Acids Res. 31, 5858−5867.
- Wahlestedt C., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
- Kurreck J., 2002, Nucleic Acids Res. 30
- Frieden M., 2003, Nucleic Acids Res. 31, 6365−6372.
- Crinelli R., 2002, Nucleic Acids Res. 30, 2435−2443.
- Santoro S. W., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
- Schubert S., 2003, DNAzymes with enhanced stability and activity, Nucleic Acids Res. 31, 5982−5992.
- Fahmy R. G., 2004, Nucleic Acids Res. 32, 2281−2285.
- Obika S., 2001, Nucleic Acids Res. Suppl., 145−146.
- Hansen J. B., 2003, Nucleosides, Nucleotides Nucleic Acids 22, 1607−1609.
- Elayadi A. N., 2002, Biochemistry 41, 9973−9981.
- Childs J. L., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
- Ittig D., 2004, Nucleic Acids Res. 32, 346−353.
- Grünweller A., 2003, Nucleic Acids Res. 31, 3185−3193.
- Braasch D. A., 2003, Biochemistry 42, 7967−7975.
- Schwarz D. S., 2003, Cell 115, 199−208.
- Arzumanov A., 2003, Oligonucleotides 13, 435−453.
- Buchini S., 2003, Curr. Opin. Chem. Biol. 7, 717−726.
- Obika S., 2000, Tetrahedron Lett., 41
- Obika S., 2001, Chem. 9, 1001−1011.
- Sun B. W., 2004, Biochemistry 43, 4160−4169.
- Goni J. R., 2004, Nucleic Acids Res. 32, 354−360.
- Hertoghs K. M., 2003, Nucleic Acids Res. 31, 5817−5830.
- Jacobsen N., 2002, Clin. Chem. 48, 657−660.
- Ørum H., 1999, Clin. Chem. 45
- Ugozzoli L. A., 2004, Anal. Biochem. 324, 143−152.
- Letertre C., 2003, Mol. Cell Probes 17, 307−311.
- Tolstrup N., 2003, Nucleic Acids Res. 31, 3758−3762.
- Silahtaroglu A. N., 2003, Mol. Cell Probes 17, 165−169.
- Sørensen M. D., 2003, Chem. Commun. 17, 2130−2131.
- Benenson Y., 2004, Nature 429, 423−429.
- Abbreviations LNA, locked nucleic acid
Cited by
Items 201–300 of 727
Papachristodoulou, A., Silginer, M., Weller, M., Schneider, H., Hasenbach, K., Janicot, M., & Roth, P. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3024 · Cited by 53
“ISTH1047 and ISTH0047 are secondgeneration ASOs that benefit from the addition of LNAmodifications, which increase their RNA binding affinity and confer enhanced nuclease resistance versus first-generation molecules (28).”
BackgroundEfficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase
Veedu, R. N., Vester, B., & Wengel, J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b819946a · Cited by 52
Self-citationKomseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
“LNAs are nucleic acid analogues “locked” by a methylene bridge that constrains them in the ideal conformation for Watson-Crick binding allowing superior hybridization properties [112] (Additional file 19: Figure S11).”
BackgroundMolecular beacons and related probes for intracellular RNA imaging
Santangelo, P. J. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.52 · Cited by 50
Dávalos, A., & Fernandez-Hernando, C. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.005 · Cited by 56
Laufer, S., & Restle, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898806 · Cited by 59
“phosphorodiamidate morpholino oligomers (PMO, [122]), locked nucleic acids (LNA, [123]), peptide nucleic acids (PNA, [124]) or 2’-O-methyl-modified oligonucleotides (OMe).”
BackgroundXu, C.-F., Yu, C., & Li, Y. (2009) · Omics · doi:10.1089/omi.2009.0035 · Cited by 48
“The hybridization process was carried out using mi-RCURY (cid:1) Array microarry kit (Exiqon) as described previously (Wienholds et al., 2005), which is based on the method of locked nucleic acid (Vester and Wengel, 2004).”
Canonical and Non-Canonical Barriers Facing AntimiR Cancer Therapeutics
Cheng, C., Saltzman, W. M., & Slack, F. J. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320290004 · Cited by 51
“LNAs are chemically modified oligonucleotides with an intramolecular methylene bridge connecting the 2’-hydroxyl and 4’-carbon [7].”
BackgroundLee, H.-C., Tan, K.-L., Cheah, P.-S., & Ling, K.-H. (2016) · Neural Plasticity · doi:10.1155/2016/7434191 · Cited by 48
Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping
Thiede, C., Creutzig, E., Illmer, T., Schaich, M. A., Heise, V., Ehninger, G., & Landt, O. (2006) · Leukemia · doi:10.1038/sj.leu.2404367 · Cited by 49
Targeting of microRNAs for therapeutics
Stenvang, J., Lindow, M., & Kauppinen, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361197 · Cited by 48
Oligonucleotide-mediated tRNA sequestration enables one-pot sense codon reassignment in vitro
Cui, Z., Wu, Y., Mureev, S., & Alexandrov, K. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky365 · Cited by 48
“Besides 2′-O-methylation, exploration of other oligonucleotide chemistries such as Locked Nucleic Acid (LNA), phosphorodiamidate morpholino oligomers (PMOs) as well as phosphorothioate derivatives (32,67,68) with a goal of increasing the heteroduplex stability and preventing their nucleolytic degradation represents th…”
BackgroundDNAzymes: Expanding the Potential of Nucleic Acid Therapeutics
Larcher, L. M., Pitout, I. L., Keegan, N., Veedu, R. N., & Fletcher, S. (2023) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0066 · Cited by 57
MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics
Alsidawi, S., Malek, E., & Driscoll, J. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610508 · Cited by 48
“nucleic acid (LNA) oligonucleotides where the ribose ring is “locked” by a methylene bridge which further increases the affinity towards single stranded RNAs [87,88], peptide nucleic acids (PNA) which are artificially synthesized polymers similar to RNAs but are resistant to enzyme degradation [89]”
BackgroundExploring the Role of Chirality in Nucleic Acid Recognition
D’Alonzo, D., Guaragna, A., & Palumbo, G. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201000303 · Cited by 46
Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges
Rodda, A. E., Parker, B. J., Spencer, A. G., & Corrie, S. R. (2018) · ACS Sensors · doi:10.1021/acssensors.7b00953 · Cited by 47
Rose, K. M., Ferreira‐Bravo, I. A., Li, M., Craigie, R., Ditzler, M. A., Holliger, P., & DeStefano, J. J. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00237 · Cited by 65
“44,60,83 Coupled with the 2 ′ fl uorine and arabinose sugar, this may allow FANA to sample unique structural spaces or make distinct interactions with amino acid moieties and domains in proteins.”
Oligonucleotide Probes for RNA‐Targeted Fluorescence In Situ Hybridization
Silverman, A. P., & Kool, E. T. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)43003-1 · Cited by 48
Kierzek, E., Pasternak, A., Pasternak, K., Gdaniec, Z., Yildirim, I., Turner, D. H., & Kierzek, R. (2009) · Biochemistry · doi:10.1021/bi9002056 · Cited by 47
“Locked nucleic acids (LNA)(1) are analogues of nucleic acids that provide large enhancements of thermodynamic stability for DNA and RNA duplexes (1-6).”
BackgroundHiguchi, M., Kobori, A., Yamayoshi, A., & Murakami, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.001 · Cited by 46
Locked and Unlocked Nucleosides in Functional Nucleic Acids
Døssing, H., & Vester, B. (2011) · Molecules · doi:10.3390/molecules16064511 · Cited by 48
“A locked nucleic acid (LNA) is a ribonucleoside homologue that features a 2’-O,4’-C-methylene linker or bridge (Figure 1) [3-5,8].”
BackgroundSelf-citationMook, O. R. F., Vreijling, J. P., Wengel, S. L., Wengel, J., Zhou, C., CHATTOPADHYAYA, J. B., Baas, F., & Fluiter, K. (2010) · Artificial DNA PNA & XNA · doi:10.4161/adna.1.1.12204 · Cited by 50
Self-citationElectrochemical Detection of miRNAs
Lautner, G., & Gyurcsányi, R. E. (2014) · Electroanalysis · doi:10.1002/elan.201400055 · Cited by 47
Fluiter, K., Mook, O. R. F., Vreijling, J. P., Langkjær, N., Højland, T., Wengel, J., & Baas, F. (2009) · Molecular BioSystems · doi:10.1039/b903922h · Cited by 45
Self-citationMicroRNAs in the skin: role in development, homoeostasis and regeneration
Horsburgh, S., Fullard, N., Roger, M., Degnan, A. E., Todryk, S. M., Przyborski, S. A., & O’Reilly, S. (2017) · Clinical Science · doi:10.1042/cs20170039 · Cited by 51
“Such examples are Locked Nucleic Acids (LNAs), whereby the ribose of the RNA nucleotide is chemically modified by the addition of a 2’-O, 4’-C-methylene bridge (113).”
BackgroundLong noncoding RNA loss in immune suppression in cancer
Hu, Q., Egranov, S. D., Lin, C., & Yang, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107591 · Cited by 46
Diallo, I., Ho, J., Lambert, M., Benmoussa, A., Husseini, Z., Lalaouna, D., Massé, É., & Provost, P. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010827 · Cited by 49
Multiplexed CRISPR-Based Nucleic Acid Detection Using a Single Cas Protein
Fu, J., Zhang, L., Long, Y., Liu, Z., Meng, G., Zhao, H., Su, X., & Shi, S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01861 · Cited by 46
Enzymatic and Chemical Synthesis of Nucleic Acid Derivatives
Eritja Casadellà, R., Aviñó, A. M., Fàbrega, C., Alagia, A., Jorge, A. F., & Grijalvo, S. (2018) · Wiley eBooks · doi:10.1002/9783527812103 · Cited by 47
End-targeting proteomics of isolated chromatin segments of a mammalian ribosomal RNA gene promoter
Ide, S., & Déjardin, J. (2015) · Nature Communications · doi:10.1038/ncomms7674 · Cited by 43
Bonnstetter, K. K., Wolter, D. J., Tenover, F. C., McDougal, L. K., & Goering, R. V. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01228-06 · Cited by 49
“the primer are indicated by a superscript L (33).”
BackgroundTherapeutic Opportunities for Targeting microRNAs in Cancer
Taylor, M. A., & Schiemann, W. P. (2014) · Journal of Green Engineering · doi:10.1186/2052-8426-2-30 · Cited by 49
“Locked nucleic acid (LNA) constructs represent a novel class of nucleic acid analogs characterized by the presence of a “locked” ribose ring generated by the formation of a methylene bridge between the 2′-O atom and the 4′-C atom [116].”
BackgroundTani, H., Miyata, R., Ichikawa, K., Morishita, S., Kurata, S., Nakamura, K., Tsuneda, S., Sekiguchi, Y., & Noda, N. (2009) · Analytical Chemistry · doi:10.1021/ac900414u · Cited by 43
Targeted Genome Modification via Triple Helix Formation
Kalish, J. M., & Glazer, P. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.023 · Cited by 43
Inhibiting Gene Expression with Locked Nucleic Acids (LNAs) That Target Chromosomal DNA
Beane, R. L., Ram, R. R., Gabillet, S., Arar, K., Monia, B. P., & Corey, D. R. (2007) · Biochemistry · doi:10.1021/bi700227g · Cited by 50
“We chose locked nucleic acids (LNAs) (6-9) to test whether efficient recognition of promoter sequences within chromosomal DNA could be extended to oligomers with phosphodiester backbones.”
BackgroundA rhythmically pulsing leaf-spring DNA-origami nanoengine that drives a passive follower
Centola, M., Poppleton, E., Ray, S., Centola, M., Welty, R. S., Valero, J., Walter, N. G., Šulc, P., & Famulok, M. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01516-x · Cited by 42
Antisense oligonucleotide based therapeutics and its applications against bacterial infections
Angrish, N., & Khare, G. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100166 · Cited by 44
Lebars, I., Richard, T., Primo, C. D., & Toulmé, J. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.11.008 · Cited by 42
Setoguchi, K., Cui, L., Hachisuka, N., Obchoei, S., Shinkai, K., Hyodo, F., Kato, K., Wada, F., Yamamoto, T., Harada‐Shiba, M., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.09.004 · Cited by 42
Nanoparticle mediated RNA delivery for wound healing
Kolanthai, E., Fu, Y., Kumar, U., Babu, B., Venkatesan, A. K., Liechty, K. W., & Seal, S. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1741 · Cited by 51
Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.
Vester, B., Hansen, L. H., Lundberg, L. B., Babu, B. R., Sørensen, M. D., Wengel, J., & Douthwaite, S. R. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-19 · Cited by 42
“Modified nucleosides in the form of conformationally locked analogues (Locked Nucleic Acid, LNA) are capable of targeting complementary RNA and DNA with high affinity [11,12], and are thus potentially interesting as components in DNAzymes.”
BackgroundSelf-citationYAMADA, K., Terahara, T., Kurata, S., Yokomaku, T., Tsuneda, S., & Harayama, S. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01518.x · Cited by 42
“Retrieval of entire genes from environmental DNA by inverse PCR with pre-amplification of target genes using primers containing locked nucleic acids OnlineOpen: This article is available free online at www.blackwell-synergy.com”
Effects of anticancer drugs on transcription factor–DNA interactions
Gniazdowski, M., Denny, W. A., Nelson, S. M., & Czyz, M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.471 · Cited by 41
“To overcome this difficulty, LNA structure was further modified by construction of α-L-ribosyl derivative inserted into the decoy oligonucleotides (α -L-LNA) [76,108].”
BackgroundMethodRobertson, K. L., & Thach, D. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.04.026 · Cited by 41
“It has been proposed that the increase in stability arises from the combination of decreased entropy of duplex formation due to the preorganization of LNA and the increased base stacking of the nucleobases [20,23–25].”
BackgroundGhobadi, A. F., & Jayaraman, A. (2016) · Soft Matter · doi:10.1039/c5sm02868j · Cited by 43
Ruthig, G., & DeRidder, B. (2011) · Diseases of Aquatic Organisms · doi:10.3354/dao02420 · Cited by 41
Synthesis and Hybridization Studies of 2‘-Amino-α-L-LNA and Tetracyclic “Locked LNA”
Kumar, T. S., Madsen, A. S., Wengel, J., & Hrdlicka, P. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo060331f · Cited by 41
Self-citationNanotheranostics in Evidence Based Personalized Medicine
SHARMA, S. K. (2014) · Current Drug Targets · doi:10.2174/1389450115666140826123552 · Cited by 40
Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells
Kaur, H., Li, J. J., Bay, B., & Yung, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0050964 · Cited by 41
Meng, X., Xu, M., Zhu, J., Yin, H., & Ai, S. (2012) · Electrochimica Acta · doi:10.1016/j.electacta.2012.03.143 · Cited by 40
Schade, M., Berti, D., Huster, D., Herrmann, A., & Arbuzova, A. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2014.02.019 · Cited by 37
Therminator DNA Polymerase: Modified Nucleotides and Unnatural Substrates
Gardner, A. F., Jackson, K. M., Boyle, M. M., Buss, J. A., Potapov, V., Gehring, A. M., Zatopek, K. M., Junior, I. R. C., Ong, J. L., & Jack, W. E. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00028 · Cited by 42
“Locked nucleic acids (LNAs) contain a ribofuranose ring in a locked, single conformation leading to duplex stabilization (Vester and Wengel, 2004).”
BackgroundNucleolar Dominance of the Y Chromosome in Drosophila melanogaster
Greil, F., & Ahmad, K. (2012) · Genetics · doi:10.1534/genetics.112.141242 · Cited by 38
Micro-RNA Expression and Function in Lymphomas
Sandhu, S. K., Croce, C. M., & Garzon, R. (2011) · Advances in Hematology · doi:10.1155/2011/347137 · Cited by 42
Dupouy, C., Tarrat, N., Durrieu, M., Rodriguez, F., Escudier, J., & Vigroux, A. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504475 · Cited by 39
MicroRNAs and micromanaging the skeleton in disease, development and evolution
He, X., Eberhart, J. K., & Postlethwait, J. H. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00696.x · Cited by 40
“The use of LNAs seems especially promising for therapies because of their high biostability, low toxicity and reasonable biodistribution after in vivo administration [80, 128].”
BackgroundThe Advantages of Being Locked
Donini, S., Clerici, M., Wengel, J., Vester, B., & Peracchi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706993200 · Cited by 37
Self-citationUnlocked Nucleic Acids for miRNA detection using two dimensional nano-graphene oxide.
Robertson, N. M., Toscano, A. E., LaMantia, V. E., Hizir, M., Rana, M., Balcioğlu, M., Sheng, J., & Yigit, M. (2017) · Biosensors & bioelectronics · doi:10.1016/j.bios.2016.02.058 · Cited by 30
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
Wani, J. A., Majid, S., Imtiyaz, Z., Rehman, M. U., Alsaffar, R. M., Shah, N. N., Alshehri, S., Ghoneim, M. M., & Imam, S. S. (2022) · Diagnostics · doi:10.3390/diagnostics12071610 · Cited by 41
Single Cell Nanobiosensors for Dynamic Gene Expression Profiling in Native Tissue Microenvironments
Wang, S., Riahi, R., Li, N., Zhang, D. D., & Wong, P. K. (2015) · Advanced Materials · doi:10.1002/adma.201502814 · Cited by 37
Scholtès, C., Icard, V., Amiri, M. V., Chevallier-Queyron, P., Trabaud, M., Ramière, C., Zoulim, F., André, P., & Dény, P. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06829-11 · Cited by 37
“Detection was done with an LNABlack Hole Quencher 1 (BHQ1) probe from Eurogentec (17) and compared to the result obtained with a TaqMan-minor groove binder (MGB) probe (Applied Biosystems) binding to the same site.”
MethodBusan, S., & Weeks, K. M. (2013) · Biochemistry · doi:10.1021/bi401129r · Cited by 43
Duckworth, A. D., Gherardini, P. F., Sýkorová, M., Yasin, F., Nolan, G. P., Slupsky, J. R., & Kalakonda, N. (2019) · Nature Protocols · doi:10.1038/s41596-018-0120-8 · Cited by 41
MicroRNA and pediatric tumors: Future perspectives
Gulino, R., Forte, S., Parenti, R., Memeo, L., & Gulisano, M. (2015) · Acta Histochemica · doi:10.1016/j.acthis.2015.02.007 · Cited by 39
Stimulation of ribosomal frameshifting by antisense LNA
Yu, C.-H., Noteborn, M., & Olsthoorn, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq650 · Cited by 36
“conformationally locked in an RNA-mimicking C30-endo/ N-type conformation (24).”
BackgroundSnellenberg, S., Schütze, D. M., Claassen-Kramer, D., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2011) · Virology · doi:10.1016/j.virol.2011.11.006 · Cited by 36
“Incorporation of LNAs in oligonucleotides has been shown to improve nucleotide discrimination (Vester and Wengel, 2004).”
BackgroundPasternak, A., Kierzek, E., Pasternak, K., Turner, D. H., & Kierzek, R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm421 · Cited by 37
“Tel: 48 62 852 85 03; Fax: 48 62 852 05 32; Email: rkierzek@ibch.poznan.pl 2007 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.0/uk/) which permits unrestricted non-commercial use, distrib…”
BackgroundInfluentialThe Sugar Conformation Governs (6-4) Photoproduct Formation at the Dinucleotide Level
Desnous, C., Babu, B. R., Moriou, C., Mayo, J. U. O., Favre, A., Wengel, J., & Clivio, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja077095q · Cited by 36
Self-citationKumar, S., Mapa, K., & Maiti, S. (2014) · Biochemistry · doi:10.1021/bi401677d · Cited by 42
Keskin, S., Besztejan, S., Kassier, G. H., Manz, S., Bücker, R., Riekeberg, S., Trieu, H. K., Rentmeister, A., & Miller, R. J. D. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.5b02075 · Cited by 37
Hanessian, S., Schroeder, B. R., Giacometti, R. D., Merner, B. L., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203680 · Cited by 35
Geny, S., Moreno, P. M. D., Krzywkowski, T., Gissberg, O., Andersen, N. K., Isse, A. J., El-Madani, A. M., Lou, C., Pabón-Martínez, Y. V., Anderson, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw021 · Cited by 36
“LNA-ONs are characterized by a conformationally restricted sugar with a methylene linkage between the 2′ oxygen and the 4′ carbon (23,24).”
BackgroundSelf-citationAndersen, N. K., Døssing, H., Jensen, F., Vester, B., & Nielsen, P. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200919y · Cited by 35
Self-citationDuplex DNA-functionalized graphene oxide: A versatile platform for miRNA sensing
Shin, B., Kim, W., Yoon, S., & Lee, J. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127471 · Cited by 36
Application of siRNA in targeting protein expression in kidney disease☆
Stokman, G., Qin, Y., Rácz, Z., Hamar, P., & Price, L. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.005 · Cited by 39
“Similar to the 2′-OM oligonucleotide approach, LNA containing antisense oligonucleotides form highly stable duplexes with high specificity for complementary RNAs [87].”
BackgroundFontenete, S., Guimarães, N., Wengel, J., & Azevedo, N. F. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2014.993589 · Cited by 39
Self-citationAntisense Oligonucleotides, A Novel Developing Targeting Therapy
Karaki, S., Paris, C., & Rocchi, P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82105 · Cited by 45
Nakamura, A., Ali, S. A., & Kapoor, M. (2020) · Bone · doi:10.1016/j.bone.2020.115461 · Cited by 36
“complementary RNA with high affinity, neutralizing the targeted RNA [31].”
BackgroundSerres‐Bérard, T. D., Benichou, S. A., Jauvin, D., Boutjdir, M., Puymirat, J., & Chahine, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113359 · Cited by 38
“The resulting reduced conformational flexibility of the ribose enhances affinity binding to RNAs and may increase the potency 5 to 10-fold with respect to 2′-MOE gapmers [32,33].”
BackgroundProperties of an ‘LNA’-modified ricin RNA aptamer
Förster, C., Zydek, M., Rothkegel, M., Wu, Z., Gallin, C., Gessner, R. V., Lisdat, F., & Fürste, J. P. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.127 · Cited by 34
Alonso, J. L., Amorós, I., & Cañigral, I. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2984-6 · Cited by 43
“Locked nucleic acids obey the Watson–Crick pairing rules but have an increased specificity and high affinity to complementary DNA (Koshkin et al. 1998; Sanjay et al. 1998; Vester and Wengel 2004; Nolan et al. 2006).”
Dupouy, C., Tarrat, N., Durrieu, M., Rodriguez, F., Escudier, J., & Vigroux, A. (2006) · Angewandte Chemie · doi:10.1002/ange.200504475 · Cited by 34
Pharmacological potential of RNAi — Focus on miRNA
Pfeifer, A., & Lehmann, H. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.006 · Cited by 36
Circulating microRNAs in oncogenic viral infections: potential diagnostic biomarkers
Hasham, K., Ahmed, N., & Zeshan, B. (2020) · SN Applied Sciences · doi:10.1007/s42452-020-2251-0 · Cited by 34
The potential role of miRNAs in multiple myeloma therapy
Caracciolo, D., Montesano, M., Altomare, E., Scionti, F., Martino, M. T. D., Tagliaferri, P., & Tassone, P. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1517041 · Cited by 32
“LNA-PS oligonucleotides are highly soluble in water and stable in biofluids, with optimal bio-distribution within tissues and long-lasting knockdown of the target in vivo [18,19].”
BackgroundDo I Understand What I Can Create? Biosafety Issues in Synthetic Biology
Schmidt, M. R. (2009) · Springer eBooks · doi:10.1007/978-90-481-2678-1_6 · Cited by 36
Expression of two microRNAs, ame-mir-276 and -1000, in the adult honeybee (Apis mellifera) brain
Hori, S., Kaneko, K., Saito, T. H., Takeuchi, H., & Kubo, T. (2010) · Apidologie · doi:10.1051/apido/2010032 · Cited by 34
“LNA is a novel bicyclic high-affinity RNA analogue that has high hybridization affinity toward cDNA ( Vester and Wengel, 2004 ).”
BackgroundIn Vitro Incorporation of LNA Nucleotides
Veedu, R. N., Vester, B., & Wengel, J. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701527844 · Cited by 32
“[1] Moreover LNA oligomers have shown their significance in antisense studies both in vitro and in vivo.[2] In recent years, sugar modified nucleoside triphosphates and their incorporation into oligonucleotides have been a topic for many researchers.”
BackgroundSelf-citationAndersson, P. U., Burel, S. A., Estrella, H., Foy, J. W.-D., Hagedorn, P., Harper, T. A., Henry, S. P., Hoflack, J.-C., Holgersen, E. M., Levin, A. A., et al. (2025) · Nucleic Acid Therapeutics · doi:10.1089/nat.2024.0072 · Cited by 39
“1,39,45,46 Irrespective of length, ASOs that only hybridize with perfect complementarity to the intended target will typically be preferred when identifying suitable on-target regions.”
Hughesman, C. B., Turner, R. F. B., & Haynes, C. A. (2011) · Biochemistry · doi:10.1021/bi200223s · Cited by 31
Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis
Toyoda, E., Maehara, M., Watanabe, M., & Sato, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073594 · Cited by 32
Zhao, Y., Chandrasekaran, A. R., Rusling, D. A., Woloszyn, K., Hao, Y., Hernandez, C., Vecchioni, S., Ohayon, Y. P., Mao, C., Seeman, N. C., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c12667 · Cited by 31
Synthesis and properties of a bridged nucleic acid with a perhydro-1,2-oxazin-3-one ring.
Shrestha, A. R., Hari, Y., Yahara, A., Ōsawa, T., & Obika, S. (2011) · Journal of Organic Chemistry · doi:10.1021/jo201597e · Cited by 24
Teixeira, A., Carreira, L., Abalde‐Cela, S., Sampaio‐Marques, B., Areias, A. C., Ludovico, P., & Diéguez, L. (2023) · Cancers · doi:10.3390/cancers15051362 · Cited by 42
“All these positive aspects of the incorporation of LNAs in PCR increase the success of the amplification and, additionally, provide a higher specificity due to the elimination of undesired products [191], and, besides PCR, it has also been integrated into Molecular Beacon, TaqMan Beacon, microarray probes, and antisen…”
BackgroundBarciszewski, J., Medgaard, M., Koch, T., Kurreck, J., & Erdmann, V. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-557-2_10 · Cited by 30
Lebars, I., Richard, T., Primo, C. D., & Toulmé, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm655 · Cited by 34
Impact of mobile and stationary phases on siRNA duplex stability in liquid chromatography
Gilár, M., Redstone, S., & Gomes, A. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465285 · Cited by 31
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?
Philippen, L. E., Dirkx, E., Wit, J. B. M., Burggraaf, K., Windt, L. J. D., & Martins, P. A. D. C. (2015) · Molecular Therapy · doi:10.1038/mt.2015.133 · Cited by 36
Zorro locked nucleic acid induces sequence‐specific gene silencing
Ge, R., Heinonen, J. E., Svahn, M. G., Mohamed, A. J., Lundin, K. E., & Smith, C. I. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-7225com · Cited by 32
Nanomedicines Based on Recombinant Fusion Proteins for Targeting Therapeutic siRNA Oligonucleotides
Winkler, J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.56 · Cited by 29
Metadata
- Authors
- Vester, B., & Wengel, J.
- Affiliations
- University of Southern Denmark (DK)
- Corresponding author
- Vester, Birte
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-10-01
- Volume
- 43
- Issue
- 42
- Pages
- 13233-13241
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2139273728
- Cited by
- 727
- References
- 57
- Citations by year
- 2026: 19 · 2025: 34 · 2024: 23 · 2023: 28 · 2022: 38 · 2021: 32 · 2020: 26 · 2019: 27 · 2018: 32 · 2017: 24 · 2016: 40 · 2015: 34 · 2014: 45 · 2013: 35 · 2012: 54
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- locked nucleic acid, LNA oligonucleotides, nucleic acid analogs, hybridization affinity, gene silencing, nucleic acid diagnostics, RNA mimics
- MeSH terms
- Endoribonucleases, Hydrolysis, Nucleic Acid Conformation, Nucleotides, Oligonucleotides, Ribose, Oligonucleotides, Antisense, RNA, Complementary, DNA, Complementary, Molecular Mimicry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.